A photosensitizer-drug conjugate for synergistic photodynamic therapy and photo-triggered camptothecin release
Open Access
- 22 May 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (13) , 6643-6652
Abstract
Red-light-responsive nanoparticles enable singlet oxygen-mediated thioketal cleavage and controlled camptothecin release for synergistic chemo–photodynamic therapy.Keywords
Funding Information
- Syracuse University
This publication has 80 references indexed in Scilit:
- Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic CancerAdvanced Science, 2021
- ROS‐Responsive Camptothecin Prodrug Nanoparticles for On‐Demand Drug Release and Combination of Chemotherapy and Photodynamic TherapyAdvanced Functional Materials, 2020
- Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin ProdrugAdvanced Materials, 2019
- Janus Nanobullets Combine Photodynamic Therapy and Magnetic Hyperthermia to Potentiate Synergetic Anti‐Metastatic ImmunotherapyAdvanced Science, 2019
- Self‐Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase‐Cleavable LinkerAdvanced Science, 2018
- ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer TherapyAdvanced Materials, 2017
- Rational Design of Cancer Nanomedicine: Nanoproperty Integration and SynchronizationAdvanced Materials, 2017
- A Red Light Activatable Multifunctional Prodrug for Image‐Guided Photodynamic Therapy and Cascaded ChemotherapyAdvanced Functional Materials, 2016
- Light‐Responsive, Singlet‐Oxygen‐Triggered On‐Demand Drug Release from Photosensitizer‐Doped Mesoporous Silica Nanorods for Cancer Combination TherapyAdvanced Functional Materials, 2016
- Near‐Infrared Photoregulated Drug Release in Living Tumor Tissue via Yolk‐Shell Upconversion NanocagesAdvanced Functional Materials, 2013